Skip to main content

Coccidioidin skin test Pregnancy and Breastfeeding Warnings

Brand names: Spherulin

Coccidioidin skin test Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Coccidioidin skin test Breastfeeding Warnings

Safety has not been established.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-It's unknown if this product is excreted in human milk.
-Proceed with caution when using this in breastfeeding women since potential exists for it to be excreted in human milk.

See references

References for pregnancy information

  1. (2023) "Product Information. Spherusol (coccidioidin skin test)." Nielsen Biosciences Inc

References for breastfeeding information

  1. (2023) "Product Information. Spherusol (coccidioidin skin test)." Nielsen Biosciences Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.